隐源性非硬化性门脉高压症患者临床和肝组织病理学表现

doi:10.3969/j.issn.1672-5069.2018.03.002

Abstract

Ji Yuan. Clinical and histopathological features of patients with idiopathoc noncirrhotic portal hypertension[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 325-328.

[1] Schouten JN,Garcia-Pagan JC,Valla DC,et al.Idiopathic non cirrhotic portal hypertension. Hepatology,2011,54(3):1071-1081.
[2] Siramolpiwat S,Seijo S,Miquel R,et al.Idiopathic portal hypertension:natural history and long-term outcome. Hepatology, 2014,59(6):2276-2285.
[3] Nicoletti V,Gioia S,Riggio O,et al. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension:description,prevalence and risk factors. Dig Liver Dis,2016 [ahead of print]
[4] Cazals-Hatem D,Hillaire S,Rudler M,et al.Obliterative portal venopathy:portal hypertension is not always present at diagnosis. J Hepatol,2011,54(3):455-461.
[5] Casillas C,Martí-Bonmatí L,Galant J.Pseudotumoral presentation of nodular regenerative hyperplasia of the liver:imaging in five patients including MR imaging. Eur Radiol,1997,7(5):654-658.
[6] Mahamid J,Miselevich I,Attias D,et al.Nodular regenerative hyperplasia associated with idiopathic thrombocytopenic purpura in a young girl:a case report and review of the literature. J Pediatr Gastroenterol Nutr,2005,41(2):251-255.
[7] Hartleb M,Gutkowski K,Milkiewicz P.Nodular regenerative hyperplasia:evolving concepts on underdiagnosed cause of portal hypertension. World J Gastroenterol,2011,17(11):1400-1409.
[8] Furuichi Y,Moriyasu F,Taira J,et al.Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. J Gastroenterol,2013,48(9):1061-1068.
[9] Khanna R,Sarin SK.Non-cirrhotic portal hypertension: Diagnosis and management. J Hepatol,2014,60(2):421-441.
[10] Pulvirenti F,Pentassuglio I,Milito C,et al.Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies. J Immunol Res,2014,2014:672458.
[11] Hillaire S,Bonte E,Denninger MH,et al.Idiopathic non-cirrhotic intra-hepatic portal hypertension in the west:a re-evaluation in 28 patients. Gut,2002,51(2):275-280.
[12] K öksal AS,K öklü S,Ibis M,et al. Clinical features,serum interleukin-6,and interferon-gamma levels of 34 Turkish patients with hepatoportal sclerosis. Dig Dis Sci,2007,52(12):3493.
[13] Cazals-Hatem D,Hillaire S,Rudler M,et al.Obliterative portal venopathy:portal hypertension is not always present at diagnosis. J Hepatol,2011,54(3):455-461.
[14] Goel A,Elias JE,Eapen CE,et al.Idiopathic non-cirrhotic intrahepatic portal hypertension(NCIPH)-newer insights into pathogenesis and emerging newer treatment options. J Clin Exp Hepatol,2014,4(3):247-256.
[15] Marzano M,Cazals-Hatem D,Rautou PE,et al.The significance of nonobstructive sinusoidal dilatation of the liver: impaired portal perfusion or inflammatory reaction syndrome. Hepathology,2015,62(3):956-963.

Clinical and histopathological features of patients with idiopathoc noncirrhotic portal hypertension

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[2]	Wu Xin, Guo Yangzhi, Du Xiaorang, et al. Clinical features of herb-induced liver injury [J]. Journal of Practical Hepatology, 2019, 22(5): 668-671.
[3]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[4]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[5]	Zhuang Taiping, Yin Yangyan, Xie Manfang, et al. Comparison of clinical features of infants with human cytomegalovirus infection and of infantile hepatitis syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 514-517.
[6]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[7]	Jiang Yi, Liu Bing. Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
[8]	Lin Lan, Shen Min, Ruan Jianwen.. Expression of programmed death receptor 1 in liver tissue of patients with autoimmune hepatitis and its clinical implications [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 204-207.
[9]	Song Fangjiao, Zhu Bing, Lyu Sa, Tian Hua, Wang Haibo, Xin Shaojie, You Shaoli. Clinical analysis of drug-induced liver failure：a report of 314 cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 216-219.
[10]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[11]	Ma Hulin, Sun Xiaoxia, Gao Weishi. Angiomyolipoma of the liver: one case report [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 291-292.
[12]	Guo Baona, Zhan Yutao.. Clinical features of alcoholic liver diseases:An analysis of 79 cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 877-880.
[13]	Zhang Haitao, Sun Hao, Li Kai, et al.. Prevalence of Helicobacter pylori infection and gastric mucosa inflammation in patients with bile reflux gastritis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 967-970.
[14]	Zheng Zhenchuan, Xu Xihai.. Pathological and clinical features and factors affecting significant liver fibrosis in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 713-716.
[15]	Zhou Zhiling, Yin Qian.. Forecasting hepatic activity index and liver fibrosis staging by serum golgiprotein-73 levels in individuals with chronic hepatitis B viral carriers [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 717-720.